Asian Stocks That Might Be Trading Below Estimated Value
Name
Current Price
Fair Value (Est)
Discount (Est)
Taiwan Union Technology (TPEX:6274)
NT$216.50
NT$424.21
49%
StemCell Institute (TSE:7096)
¥1070.00
¥2118.09
49.5%
Shenzhen KSTAR Science and Technology (SZSE:002518)
CN¥21.98
CN¥43.55
49.5%
PixArt Imaging (TPEX:3227)
NT$219.50
NT$436.51
49.7%
Peijia Medical (SEHK:9996)
HK$6.43
HK$12.71
49.4%
Livero (TSE:9245)
¥1719.00
¥3376.98
49.1%
Good Will Instrument (TWSE:2423)
NT$43.90
NT$87.32
49.7%
Food & Life Companies (TSE:3563)
¥6579.00
¥12942.09
49.2%
Dive (TSE:151A)
¥917.00
¥1832.47
50%
cottaLTD (TSE:3359)
¥442.00
¥866.08
49%
Click here to see the full list of 292 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
We'll examine a selection from our screener results.
Overview: Celltrion, Inc. is a biopharmaceutical company focused on developing, producing, and selling therapeutic proteins for oncology treatments with a market cap of ₩35.78 trillion.
Operations: Celltrion generates revenue from its Biopharmaceutical segment, amounting to ₩6.18 trillion, and its Chemical Drugs segment, which contributes ₩523.71 million.
Estimated Discount To Fair Value: 15.6%
Celltrion appears undervalued based on cash flow analysis, trading at 15.6% below its estimated fair value of ₩191,807.09. Despite a modest undervaluation, the company shows promising growth prospects with earnings expected to grow significantly at 27.2% annually, outpacing the Korean market average of 21%. Recent strategic moves like share buybacks aim to enhance shareholder value while an expanded FDA designation for YUFLYMA® supports long-term revenue growth potential in biosimilars.
The analysis detailed in our Celltrion growth report hints at robust future financial performance.
Click here to discover the nuances of Celltrion with our detailed financial health report.
Overview: Akeso, Inc. is a biopharmaceutical company focused on the research, development, manufacture, and commercialization of antibody drugs globally, with a market cap of HK$88.73 billion.
Operations: The company's revenue primarily comes from the research, development, production, and sale of biopharmaceutical products, totaling CN¥2.12 billion.
Estimated Discount To Fair Value: 28.5%
Akeso is trading at HK$98.85, well below its estimated fair value of HK$138.35, suggesting undervaluation based on cash flows. The company is poised for significant growth with earnings forecasted to increase 58.28% annually and expected profitability within three years, surpassing market averages. Recent regulatory approvals for innovative treatments like cadonilimab and ivonescimab bolster Akeso's position in oncology, potentially driving revenue growth as these therapies address critical unmet needs in cancer treatment across China and internationally.
Our earnings growth report unveils the potential for significant increases in Akeso's future results.
Get an in-depth perspective on Akeso's balance sheet by reading our health report here.
Overview: HMT (Xiamen) New Technical Materials Co., Ltd. operates in the technical materials industry with a market cap of CN¥13.39 billion.
Operations: The company generates revenue from the Automobile Parts Manufacturing Industry, amounting to CN¥2.28 billion.
Estimated Discount To Fair Value: 34.5%
HMT (Xiamen) New Technical Materials is trading at CNY 40.69, significantly below its estimated fair value of CNY 62.09, indicating undervaluation based on cash flows. The company's earnings are projected to grow at 22.24% annually, outpacing the market's revenue growth rate of 12.4%. Recent developments include a private placement and share buyback program, which may enhance shareholder value despite a decrease in dividends and slower profit growth compared to the market average.
Our comprehensive growth report raises the possibility that HMT (Xiamen) New Technical Materials is poised for substantial financial growth.
Navigate through the intricacies of HMT (Xiamen) New Technical Materials with our comprehensive financial health report here.
Access the full spectrum of 292 Undervalued Asian Stocks Based On Cash Flows by clicking on this link.
Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSE:A068270 SEHK:9926 and SHSE:603306.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
LexinFintech Holdings (LX) Announces Unaudited Results for Fiscal Q2 2025
LexinFintech Holdings Ltd. (NASDAQ:LX) is one of the top cheap stocks that will go to the moon according to Reddit. LexinFintech Holdings Ltd. (NASDAQ:LX) announced its unaudited financial results for fiscal Q2 2025 on August 7, reporting a revenue of RMB 3.59 billion, up 15.6% quarter-over-quarter. A business professional using the company's technology-driven platform to access location-based services for a shopping experience. Profit (Non-GAAP EBIT) for the quarter reached RMB 670 million, up 15.2% quarter-over-quarter and 116.4% year-over-year. Management reported that Q2 profit was 'the highest in 14 quarters, marking the fifth straight quarter of sequential growth, while multiple core business indicators continued to improve.' Headquartered in Shenzhen, China, LexinFintech Holdings Ltd. (NASDAQ:LX) is involved in the business of matching consumers with credit needs with its financial institution partners via its proprietary platform and mobile application. While we acknowledge the potential of XXXX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Taiwan Semiconductor Manufacturing (TSM) Announces Net Revenue for July 2025
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the best stocks to invest in for beginners. On August 8, Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) announced its net revenue for July 2025. A close-up of a complex network of integrated circuits used in logic semiconductors. Management reported that revenue for July on a consolidated basis was around NT$323.17 billion, reflecting a growth of 22.5% compared to June 2025 and an increase of 25.8% compared to July 2024. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) also reported that revenue for January through July 2025 totaled NT$2,096.21 billion, a growth of 37.6% compared to the same period last year. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is the largest contract semiconductor manufacturer in the world. Some of its prominent customers include semiconductor companies that outsource all or part of their chip production, including Advanced Micro Devices, Nvidia, Broadcom, and more. While we acknowledge the potential of TSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
Why the U.S. and China Are Playing Nice
Credit - Getty Images The U.S. and the People's Republic of China are strategic rivals in the battle for global leadership in the 21st century. So it was no surprise when President Donald Trump hit China with 20% tariffs in the first few weeks of his second term and then imposed reciprocal tariffs of 34% on 'Liberation Day.' And when Trump a few days later lowered tariff rates for everyone else to calm markets, he quadrupled duties on China to a whopping 145%. But all that now feels like ancient history. Over the past four months, Trump has bent over backwards to be kind to Beijing. The two sides announced a 90-day ceasefire in Geneva in early May, agreeing to reduce tariffs and negotiate their differences over export controls and other issues. (Remaining U.S. tariffs on China are still at roughly 55%, and China's tariffs on the U.S. stand at almost 33%. These are historically high levels, but not sufficient to outright stop trade.) Further discussions in London and Stockholm made enough progress for the two sides this week to announce another extension of the ceasefire, with the White House praising Beijing for being cooperative and flexible in the negotiations to date. Read More: Why Trump Will Blink First on China In the same vein, the Trump Administration has not shut down TikTok in the U.S. despite the fact that it is still Chinese-controlled, in contravention of American law; it denied a transit visa for Taiwanese President William Lai; and it is allowing Nvidia and AMD to sell advanced chips in China despite originally blocking many of these sales, following a pay-for-play deal. So why the sudden about-face on China? It is doubly odd given the U.S.'s simultaneous tough tact toward other members of the BRICS—a rival to the U.S.-led G7 that includes Brazil, Russia, India, and South Africa—not to mention many of America's traditional allies. Three reasons stand out. First, both Washington and Beijing now have proven weapons that are restraining the aggressive instincts of the other side. Unlike others who caved in to Trump's pressure, Beijing retaliated, first with its own high tariffs, and then, more importantly, with restrictions on rare earth minerals, over which they have a global chokehold. Once Trump began lowering most of the initial reciprocal tariffs and calling for talks with Xi, they had confidence that restricting rare earths minerals and magnets would be met not with counterstrikes but with concessions. That includes the Trump Administration backing off imposing new export controls on several technologies and scrapping their threat to 'aggressively revoke' Chinese student visas. Beijing now believes it has perfected the recipe for making a 'TACO' ('Trump always chickens out'). Second, Trump and Xi both have an interest in strengthening economic confidence at home. With persistent overcapacity and price wars across industrial and consumer sectors, 'involution' has become the word of the year in China, a nod to the excessive competition that is hurting local businesses. Xi needs to shore up government finances, consolidate industries, and avoid further international barriers to Chinese exports and investment. The U.S.'s current economic picture is stronger, but constituents in town halls across the country have expressed deep worries about lost export markets, inflation, budget deficits, and a potential recession. Third, both Trump and Xi want to meet each other, most likely in the Fall in Asia. Trump has been signaling his desire for direct communication with Xi since at least April. He wants to assemble a deal that he can sell at home as boosting U.S. business opportunities and stopping the fentanyl epidemic, given China's role in producing most of the precursors in the synthetic opiod that is trafficked to America. The Chinese have played hard to get, privately saying any summit must be preceded by detailed negotiations and planning. Based on my conversations with experts in China in recent weeks, Xi wants to avoid being disrespected, as Ukrainian President Zelensky and other world leaders were during their White House visits. And with Trump making concession after concession, Beijing may want to consolidate its recent gains and aim even higher, perhaps inducing Trump to make further compromises over tariffs, export controls, and Taiwan. Read More: It's Time for Trump and Xi to Meet Although one should not dismiss the value of stable ties between the world's two largest economies, each equipped with massive stockpiles of nuclear weapons, this warming trend is unlikely to last very long. Both sides prefer calmness now because it aligns with their short-term interests. Chinese official rhetoric aside, neither side sees the relationship in cooperative terms, and neither is willing to take major steps to provide strategic reassurance to the other. The underlying fundamental challenges created by the countries' deep divisions over their economic ties, the potential for conflict over Taiwan and other hotspots, and their competing visions of the international order can only be papered over for so long. At some point Beijing may run out of luck, and either not concede enough in negotiations or push too hard to make a TACO, and instead generate a Trumpian tirade or policy overreaction. Trump's unpredictability make linear extrapolations of any U.S. policy or strategy a risky bet. At some point, for either reasons of policy or fashion, the U.S.'s current gentle approach toward Beijing is likely to eventually harden, and for a new scene in the drama to unfold. Read More: Why China Can't Win a Trade War Beijing knows no deal with Trump is permanent. They will enjoy the peace and quiet as long as they can, but they know they need to be prepared for the next round of escalation—whenever it arrives. Other countries, companies, and markets should, too. Contact us at letters@ Solve the daily Crossword
